Input to Government’s Industrial Strategy

Interim Report: North East Pharmaceutical Industry Engagement April 2017 – Compiled by John Sandles & Prof Michael Whitaker. Written by John Sandles. Executive summary The North East pharmaceutical manufacturing industry enjoys high productivity and has an estimated UK annual GVA impact of [...]

CPhI Pharma Insights: R&D Report

CPhI report shows R&D market diversifying innovation, with increased partnerships, mergers and revenue sharing models. R&D sector to grow at over 8% driven by new evaluation techniques. Report highlights: Increased collaboration across industry, with three quarters partnering and 20% [...]

Giving the animals a break

  The ABPI has welcomed government plans to reduce and refine animal testing in the UK. Following the release of new government plans that outline strategies for reducing the use of animals in drug testing, the Association of the British Pharmaceutical Industry (ABPI) has spoken publicly [...]

EMA and FDA partners in pharma safety

  The EMA and FDA have announced plans for a new collaboration to strengthen their individual efforts towards maintaining medicine safety. In a recently released joint statement, the European Medicines Agency (EMA) and the US Food and Drug Association (FDA) confirmed they are entering into [...]

Report calls on government to secure UK

Businesses and government must adapt to ensure manufacturing continues to play a powerful role in the UK economy, or risk being left behind international competitors, according to a new report published today. ‘The Future of Manufacturing: A new era of opportunity and challenge for the UK’ [...]

NICE boss demands higher uptake of drugs

NICE chairman urges patients to be more proactive in seeking treatment as the uptake of approved drugs dips below expectations. Professor David Haslam, chairman of the National Institute of Health and Care Excellence (NICE), has called on patients to position themselves as “equal partners” with [...]

Industrial Biotechnology Catalyst Fund OPEN:

The Biotechnology and Biological Sciences Research Council (BBSRC), the Technology Strategy Board and the Engineering and Physical Sciences Research Council (EPSRC) are to invest £45m in major integrated research and development projects through the Industrial Biotechnology Catalyst. Catalysts [...]

Nobel Prize in Physics recognises

The award of the Nobel Prize in Physics to the men behind the Higgs boson “recognises a truly fundamental conceptual achievement in particle physics”, according to a Durham University expert. Professor Valentin Khoze, Director of Durham’s Institute for Particle Physics Phenomenology (IPPP), was [...]

Horizon 2020: What to Expect

H2020 is the chief financial assistance for research and innovation in Europe and aims to provide support for problems often faced by many early-stage R&D developments. Running from 2014 to 2020, with a proposed budget of €80 billion (46% higher than that of FP7), the project aims to [...]

UK’s Cancer Drugs Fund given new lease of life

The UK government has confirmed its special funding arrangement for certain cancer drugs will continue for an extra two years until March 2016. The £600m Cancer Drugs Fund was set up in 2011 as a temporary arrangement to provide patients in England with access to drugs not backed by NICE but [...]

UK pharmacists get social media guidance

Pharmacists in the UK are being encouraged to use social media in their professional lives by the Royal Pharmaceutical Society (RPS). The professional body has produced a wide-ranging package of tools and information to help pharmacists approach the likes of Twitter and Facebook to build a [...]

Best pharma/NHS partnerships pick up awards

     “Many people call joint working innovative but it’s really common sense. The key is patient benefit, and this is something where both sides can be rewarded,” said the Department of Health’s Naima Khondkar, speaking at PharmaTimes’ Partnerships in Health Networking Day and Awards on 12 [...]

CPhI Pharma Insights: R&D Report Copy

   “Many people call joint working innovative but it’s really common sense. The key is patient benefit, and this is something where both sides can be rewarded,” said the Department of Health’s Naima Khondkar, speaking at PharmaTimes’ Partnerships in Health Networking Day and Awards on 12 [...]

Biomedical Catalyst to re-open on 29 July 2013

  The UK’s innovation agency, the Technology Strategy Board’s announcement today that the Biomedical Catalyst will reopen for applications for early- and late-stage awards on 29 July 2013 is welcome. The announcement follows a successful campaign and confirmation at the Spending Review of [...]

Call for Company

  Taking place in Manchester on 18th September 2013, BioCap is the only Life Sciences and Investment Conference based in the North of England. Bringing together international investors and companies both seeking finance and with a track record of raising finance, this not to be missed [...]

UK breast cancer diagnoses jump in younger women

The rate of younger women diagnosed with breast cancer in the UK has hit the 10,000 mark for the first time. This is according to new statistics released by Cancer Research UK that shows in 2010, just over 10,000 women under 50 were diagnosed in the UK with the disease, compared with 7,712 [...]

Lilly tops the poll for best sales reps

Lilly has come first in the industry’s biggest customer satisfaction survey for best medical sales representatives, jumping from third place last year, and shunting Pfizer into second place, while AstraZeneca moved to third place from last year’s position at number two. More than 1,300 [...]

Medicines optimisation: new good practice guide

New good practice guidance for medicines optimisation has been launched today by the Royal Pharmaceutical Society (RPS). It is endorsed by NHS England, medical Royal Colleges and the Association of the British Pharmaceutical Industry (ABPI). The document sets out four guiding principles to help [...]

Customer experience for pharma companies

It’s a strange time in pharmaceutical marketing. Just when most industries are finding it easier to reach customers than ever before, pharma companies are finding it more difficult. As drugs fall off the patent cliff, marketing budgets are being slashed. As regulators get tougher, [...]

UK pharma gets digital ad monitoring system

Ebiquity, the independent media-benchmarking consultancy, has launched the first digital system for the UK healthcare/pharma market, called Ebiquity Portfolio Healthcare. The service is specifically designed to gather data on prescription-only products and is intended to give insight into [...]

ColaLife rides Coke

  Simon Berry is piggybacking on Coca-Cola’s distribution system to bring life-saving medicine to the places that need it most. You can buy a Coke pretty much anywhere on Earth. Thanks to a vast network of local suppliers, Coca-Cola has almost completely solved distribution, getting [...]

Contact Us

Send us an email and we'll get back to you asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search